Remove Biosimilars Remove Department of Veterans Affairs Remove Hospitals
article thumbnail

Go-To-Patient Strategy- 2033

PharmaState Academy

Department of Veterans Affairs found that “patients’ health outcomes improve when physicians individualize care and take their patients’ life circumstances into account.” In the coming age of biopharmaceuticals and biosimilars, every patient will have different needs, especially young patients with life-style disease problems.

article thumbnail

NHC Submits Comments to CMS RE CY 2026 Policy & Technical Changes to MA and Part D Proposed Rule

Putting Patients First Blog

AOMs are already covered under various other insurance programs, including the Federal Employees Health Benefits Program, Medicaid, the Department of Veterans Affairs, TRICARE, commercial insurance plans, and state employee health plans. 2 Effective management requires a comprehensive approach.